# Enhanced, Personalized and Integrated Care for Infection Management at the Point-Of-Care

> **NCT04013737** · — · COMPLETED · sponsor: **Imperial College London** · enrollment: 33 (actual)

## Conditions studied

- Antibiotic Resistant Infection
- Infection

## Interventions

- **DEVICE:** EPIC IMPOC

## Key facts

- **NCT ID:** NCT04013737
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-28
- **Primary completion:** 2019-08-08
- **Final completion:** 2019-08-08
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2021-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04013737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04013737, "Enhanced, Personalized and Integrated Care for Infection Management at the Point-Of-Care". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04013737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
